Simple Blood Test Predicts Obesity

According to new research from the Monell Center, the degree of change in blood triglyceride levels following a fatty meal may indicate susceptibility to diet-induced obesity. The findings open doors to new methods of identifying people, including children, who are at risk for becoming obese.

Triglycerides are a form of fat that is transported in the blood and stored in the body's fat tissues. They are found in foods and also are manufactured by... read more

Submitted by Avera

• 74 Views
• 0 Comments

New Research Shows That Combining Aerobic Exercise With High-Force Eccentric Resistance Training Improves Glucose Control in Diabetes Patients

ALEXANDRIA, Va., Oct 31, 2008 /PRNewswire-USNewswire via COMTEX/ -- Physical therapy is a cost-effective form of treatment for Americans with diabetes
Patients with diabetes who participate in a program combining aerobic and high-force eccentric resistance exercise demonstrate improvements in glucose control, physical performance, and body fat composition, according to a study published in the November 2008 issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA).
"Although aerobic... read more

Submitted by Avera

• 78 Views
• 0 Comments

Pregnancy Weight Gain, Big Babies Linked

Oct. 31, 2008 -- Gaining 40 pounds or more during pregnancy nearly doubles the risk of having a baby who weighs 9 pounds or more, in turn increasing the health risks to mother and baby, according to a new study.

Excessive pregnancy weight gain and big babies have often been linked, says Teresa Hillier, MD, senior investigator at the Kaiser Permanente Center for Health Research, Portland, Ore., and the study's lead author. Researchers have also... read more

Submitted by Avera

• 71 Views
• 0 Comments

NICE Approves Spinal Cord Stimulation For Chronic Neuropathic Pain, UK

People living a life of constant pain will now have access to Spinal Cord Stimulation (SCS) following new guidance issued by the National Institute for Health and Clinical Excellence (NICE) on Wednesday 22nd October 2008.1

The new guidance from NICE recommends that Spinal Cord Stimulation should be made available to all patients who continue to experience chronic neuropathic pain for at least 6 months despite trying conventional approaches to pain management. Patients will also... read more

Submitted by Avera

• 86 Views
• 0 Comments

Cone Shell Toxin Offers New Hope For Chronic Pain Sufferers

Better chronic pain relief could be possible in the future, according to research announced today by scientists at UQ's Queensland Brain Institute.

Neuropathic and chronic pain is typically caused by injury to the nerves, resulting in uncontrolled activation of pain pathways, and affects one in five Australians of working age.

Neuroscientists at QBI have revealed that a toxin produced by a lethal cone snail acts on a newly identified target and cell signalling... read more

Submitted by Avera

• 180 Views
• 0 Comments

Geisinger research: Antimalarial drug prevents diabetes in arthritis patients

DANVILLE, PA - The use of an antimalarial medication may prevent the onset of diabetes in patients with rheumatoid arthritis, new Geisinger research shows.

Researchers examined the records of 2,093 Geisinger patients who received treatment for rheumatoid arthritis from 2000 to 2008. The study looked at, among other things, use of the medication hydroxychloroquine (HCQ) and the development of new cases of diabetes in these patients.

HCQ was developed to treat malaria but... read more

Submitted by Avera

• 75 Views
• 0 Comments

Do Spiders Spook You More Than Diabetes?

Oct. 28, 2008 -- A new survey looks at what Americans are most afraid of, and the results may surprise you.

They show that people are more afraid of things that are rarely likely to happen.

Submitted by Avera

• 90 Views
• 1 Comment

Study Explains Long-Term Failure of Diabetes Drug

TUESDAY, Oct. 28 (HealthDay News) -- Mice chronically treated with a sulfonylurea become diabetic and have reduced insulin secretion, which is reversible by stopping treatment, according to an article in the October issue of PLoS Medicine. This may explain the long-term treatment failure observed in diabetic patients treated with sulfonylureas.

Maria Sara Remedi, Ph.D., and Colin G. Nichols, Ph.D., from Washington University School of Medicine in St. Louis implanted mice with slow-release sulfonylurea (glibenclamide)... read more

Submitted by Avera

• 98 Views
• 0 Comments

South Africa: Suppository Insulin Pill to Be Tested in Country

Israeli biotechnology company Oramed Pharmaceuticals plans to test the safety of its suppository insulin pill on diabetics in SA.

The trial, which will be conducted by local clinical research organisation OnQ Consulting, highlights international drug developers' confidence in the local industry.

"The level of medical expertise is high in SA, and the pricing is very competitive," Oramed CEO Nadav Kidron said.

With a growing number of diabetics worldwide, pharmaceutical companies are hunting for new and... read more

Submitted by Avera

• 67 Views
• 0 Comments

Artificial Pancreas Could Revolutionize Treatment Of Type 1 Diabetes

Researchers at the University of Virginia and sites across the globe are testing a computerized, subcutaneous system that could one day transform the way Type 1 diabetics manage their disease.

UVA investigators have completed the first of several international artificial pancreas clinical trials to test an individually-"prescribed" control algorithm, which regulates blood glucose levels in Type 1 diabetics. UVA is one of seven centers worldwide funded by the Juvenile Diabetes Research Foundation to perform the... read more

Submitted by Avera

• 81 Views
• 0 Comments